Bone Marrow Transplant
Dr. Paolo Anderlini, MD
- Medicare services, 2022
- 209
- Part D claims, 2022
- 31
- Publications
- 205
- Clinical trials
- 7
- Industry payments
- $8,100
- Practice address
- 600 N Wolfe St, Baltimore, MD 21287
- Practice phone
- Call (713) 792-6161
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Anderlini's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paolo Anderlini is a medical oncologist in Baltimore, Maryland
Dr. Anderlini practices in Baltimore, Maryland.
Dr. Anderlini's NPI, 1134214190, was assigned on October 4, 2006. Dr. Anderlini graduated from University of Modena Faculty of Medicine in 1986. Dr. Anderlini's Texas license number on file is K2638.
- NPI
- 1134214190NPI Registry (opens in a new tab)
- NPI enumeration date
- October 4, 2006
- NPI status
- Active
- Practice phone
- (713) 792-6161
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Paolo Anderlini's practice address is in Baltimore, Maryland
Dr. Anderlini's practice address in the NPI Registry is 600 N Wolfe St, Baltimore, MD 21287, in Baltimore City. The practice phone is (713) 792-6161.
- NPI Registry address600 N Wolfe St, Baltimore, MD 21287 · Baltimore CityPhone(713) 792-6161
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Paolo Anderlini's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderlini practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Anderlini's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paolo Anderlini is one of 157 medical oncologists in Maryland
Medical oncology is Dr. Anderlini's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Anderlini is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Anderlini's licenses on file in 3 states: Texas, Florida and Oklahoma.
Specialties and state licenses
- Medical oncology, TexasPrimary
- Florida license
- Oklahoma license
Medical oncologists near Dr. Anderlini
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paolo Anderlini billed Medicare for 209 services in 2022
CMS data shows 209 Medicare services from Dr. Anderlini across 5 procedure codes in 2022. Medicare paid $16,926 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Anderlini's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 1872022: 11837%
- Surgery
- 2021: 2402022: 9162%
Dr. Anderlini compared with the Maryland median for medical oncologists, 2022
- Dr. Anderlini
- Maryland median
- Medicare services
- 209vs 42250% below
- Part D claims
- 31vs 11874% below
Medians across 124 medical oncologists in Maryland with Dmand AI profiles that report each measure.
Dr. Anderlini's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Anderlini?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Anderlini and other medical oncologists in Maryland.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paolo Anderlini's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Anderlini's median patient age at 70, with 25% women.
Dr. Anderlini's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women25%
- Men75%
Source: Dmand AI Patient Panel Data
Dr. Paolo Anderlini wrote 31 Medicare Part D claims in 2022
In 2022, Dr. Anderlini wrote 31 Medicare Part D claims. They cover 2 drugs, with $484 in total drug cost. In 2021, CMS named 25 claims across 2 drugs.
Dr. Anderlini's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 252022: 3124%
Drugs named by CMS: 2 in 2022, 2 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paolo Anderlini has 205 publications on record
Dmand AI links 205 papers to Dr. Anderlini, published from 2003 to 2024. 2015 was the busiest year, with 16. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Graft vs Host Disease. Dr. Anderlini has published most often in Biol Blood Marrow Transplant. Dr. Anderlini's most frequent co-authors are Richard E. Champlin, MD, Issa F. Khouri, MD and Chitra Hosing, MD.
Dr. Anderlini's papers by year, 2014 to 2024
Topics Dr. Anderlini writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation, Homologous
- Graft vs Host Disease
- Transplantation Conditioning
- Antineoplastic Combined Chemotherapy Protocols
- Granulocyte Colony-Stimulating Factor
- Recombinant Proteins
- Bone Marrow Transplantation
Dr. Anderlini's most frequent co-authors
- Richard E. Champlin, MD138 shared papers
- Issa F. Khouri, MD78 shared papers
- Chitra Hosing, MD77 shared papers
Recent publications by Dr. Anderlini
Transplant Cell Ther
See who Dr. Anderlini researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Anderlini works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paolo Anderlini has worked on 7 clinical trials
Dmand AI links Dr. Anderlini to 7 clinical trials. Conditions studied include Anemia, Aplastic, Bone Marrow Failure Disorders and Hodgkin Disease. M.D. Anderson Cancer Center sponsors the most, 4.
Clinical trials with Dr. Anderlini by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Anderlini's trials
- Anemia, Aplastic
- Bone Marrow Failure Disorders
- Hodgkin Disease
- Lymphoma
- Myeloproliferative Disorders
Investigators on the most trials with Dr. Anderlini
- Joel Aaron Brochstein, MD2 shared trials
- Philip Louis McCarthy, MD2 shared trials
- Roberta H. Adams, MD1 shared trial
Recent clinical trials with Dr. Anderlini
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) (opens in a new tab)
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease (opens in a new tab)
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) (opens in a new tab)
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paolo Anderlini received $8,100 in industry payments from 2016 to 2019
CMS Open Payments shows 22 general payments to Dr. Anderlini from 3 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 81% of the total. Shire North American Group Inc paid the most, $7,789.
General payments to Dr. Anderlini by program year, 2016 to 2019
General payments to Dr. Anderlini by kind, 2016 to 2019
- Consulting fees$6,60081%
- Travel and lodging$97512%
- Food and beverage$3354%
- Education$1902%
Companies that paid Dr. Anderlini the most, 2016 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Paolo Anderlini graduated from University of Modena Faculty of Medicine
Dr. Anderlini graduated from University of Modena Faculty of Medicine in 1986. Dr. Anderlini is a member of ASCO.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Paolo Anderlini accepts plans from 13 insurance carriers
Dr. Anderlini is in network with 13 carriers, including United Healthcare, Aetna and Alliant Health Plans. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.
- United Healthcare
- Aetna
- Alliant Health Plans
- Elevance
- HCSC
- Baylor Scott and White
- Blue Cross and Blue Shield of Kansas City
- Blue Cross Blue Shield of Michigan
- +5 more carriersWith a free account
Plan types Dr. Anderlini accepts, by number of carriers
- HMO8
- PPO7
- EPO2
- POS2
- Medicare1
Source: Dmand AI Insurance Network Data
Sources for Dr. Paolo Anderlini's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paolo Anderlini
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paolo Anderlini's NPI number?
Dr. Paolo Anderlini's NPI number is 1134214190. It was assigned on October 4, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paolo Anderlini?
Dr. Paolo Anderlini is a medical oncologist in Baltimore, Maryland. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Paolo Anderlini practice?
Dr. Anderlini practices at 600 N Wolfe St, Baltimore, MD 21287.
What is Dr. Paolo Anderlini's office phone number?
The practice phone on file for Dr. Anderlini is (713) 792-6161.
What is Dr. Paolo Anderlini's medical license number?
Dr. Anderlini's Texas license number on file is K2638, one of the licenses on file in 3 states.
Which states has Dr. Paolo Anderlini been licensed in?
Dmand AI has state licenses on file for Dr. Anderlini in Texas (1997 to 2024), Florida (since 2021) and Oklahoma (2020 to 2021).
Does Dr. Paolo Anderlini accept Medicare?
Yes. CMS data shows Dr. Anderlini billed Medicare for 209 services in 2022.
Is Dr. Paolo Anderlini board certified?
Yes. Dr. Anderlini is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Paolo Anderlini bill to Medicare?
In 2022, Dr. Anderlini's most billed Medicare services were hospital inpatient care (99233), surgery: blood and lymph system (38206) and surgery: heart and blood vessels (36514).
Where did Dr. Paolo Anderlini go to medical school?
Dr. Anderlini graduated from University of Modena Faculty of Medicine in 1986.
Show 6 more questionsShow fewer questions
What drugs does Dr. Paolo Anderlini prescribe most?
In 2022 Medicare Part D data, Dr. Anderlini's most prescribed drugs by claims were Valacyclovir and Sulfamethoxazole-Trimethoprim.
Has Dr. Paolo Anderlini received payments from drug or device companies?
CMS Open Payments shows $8,100 in general payments to Dr. Anderlini from 3 companies from 2016 to 2019. The largest total came from Shire North American Group Inc.
How long has Dr. Paolo Anderlini been practicing?
Dr. Anderlini graduated from medical school in 1986, 40 years ago.
Does Dr. Paolo Anderlini do research?
Dmand AI links 205 publications to Dr. Anderlini, published from 2003 to 2024. Dr. Anderlini has worked on 7 clinical trials.
Who does Dr. Paolo Anderlini publish with?
Dr. Anderlini's most frequent co-authors are Richard E. Champlin, MD (138 shared papers), Issa F. Khouri, MD (78 shared papers) and Chitra Hosing, MD (77 shared papers).
What insurance does Dr. Paolo Anderlini accept?
Dr. Anderlini is in network with 13 carriers, including United Healthcare, Aetna and Alliant Health Plans. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card